Macrocyclic Indole Derivatives for HCV Polymerase Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hepatitis C virus (HCV) infections are inadequate, and there is a need for effective inhibitors of the virus's RNA polymerase to prevent and treat the infection.
Innovation Solution
Development of macrocyclic indole derivatives, specifically compounds of formula (I) and their pharmaceutically acceptable salts, which are designed to inhibit HCV RNA polymerase, thereby preventing and treating HCV infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for hepatitis C virus infections, then treatment options are limited, but therapeutic effectiveness is inadequate
Solution Approach 1:
The patent modifies chemical parameters of indole derivatives by changing substituents at positions R1, R2, Ar, W, X, Y, and Z to create compounds with optimized inhibitory activity against HCV RNA polymerase. This involves systematic variation of molecular structure parameters including aromatic ring substitutions, heteroatom types, and side chain configurations to achieve potent antiviral effects while maintaining selectivity
Solution Approach 2:
The invention creates composite molecular structures combining indole core with macrocyclic frameworks and various functional groups (amides, esters, heteroaromatic rings). These composite structures integrate multiple pharmacophoric elements that work synergistically to inhibit HCV replication, providing both potency and a foundation for developing diverse treatment regimens
2Reliability
If macrocyclic indole derivatives are developed to inhibit HCV RNA polymerase, then antiviral activity is improved, but molecular complexity increases
Solution Approach 1:
The macrocyclic indole derivatives are designed with distinct functional segments: an indole core unit, macrocyclic ring structures, aromatic substituents (Ar), and various side chains (R1, R2, R3). This segmentation allows each part to contribute specific functions - the indole core provides binding affinity, the macrocycle confers structural rigidity and selectivity, while substituents fine-tune pharmacokinetic properties and enhance potency
Solution Approach 2:
The patent applies local quality by introducing specific functional groups at strategic positions on the molecular framework. For example, electron-withdrawing or electron-donating groups are placed at specific aromatic ring positions to optimize electronic distribution for polymerase binding, while hydrophobic or hydrophilic substituents are positioned to match the binding pocket characteristics of HCV RNA polymerase, thereby enhancing inhibitory activity without uniformly increasing complexity throughout the molecule
Data Source
AI summary
A class of macrocyclic compounds of formula (I), wherein R7, A, Ar, B, D, F, M, Q1, Q2, W, X, Y and Z are defined herein, that are useful as inhibitors of viral proteases, particularly the hepatitis C virus (HCV) NS3 protease, are provided. Also provided are processes for the synthesis and use of such macrocyclic compounds for treating or preventing HCV infection.